ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,889Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 98

$86K Total Retail Price of All Prescriptions

Rank: 72 out of 98

244 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 244 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 9,967 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$8 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
ASPIRIN EC 520 469 1 99
VITAMIN B-12 391 356 10 2 128
LISINOPRIL 387 360 3 3
OMEPRAZOLE 362 349 4 6
SIMVASTATIN 362 352 4 2
LEVOTHYROXINE SODIUM 314 275 6 5
FUROSEMIDE 307 284 7 4
DOK 296 269 8 131
MULTIVITAMINS 279 272 9 157
VITAMIN D 274 251 10 142
CITALOPRAM HBR 265 259 11 10
TRAZODONE HCL 199 186 12 9
SERTRALINE HCL 176 169 13 19
SENNA-GEN 176 160 13 191
HYDROCHLOROTHIAZIDE 172 153 15 17
AMLODIPINE BESYLATE 169 167 16 7
MAPAP 160 147 17 150
METOPROLOL TARTRATE 155 149 18 8
FERROUS SULFATE 130 118 19 213
METFORMIN HCL 127 126 20 15
WARFARIN SODIUM 125 125 21 1
ATENOLOL 125 125 21 14
CALCIUM WITH VITAMIN D 118 115 23 147
MIRTAZAPINE 117 115 24 11
ALENDRONATE SODIUM 106 100 25 30
POTASSIUM CHLORIDE 103 90 26 21
LORATADINE 103 98 26 233
GABAPENTIN 89 79 28 13
TAMSULOSIN HCL 86 86 29 25
FLUTICASONE PROPIONATE 85 81 30 53
DIVALPROEX SODIUM 85 65 30 22
PROVENTIL HFA 84 59 32 247
CALCIUM ANTACID 82 82 33 249
ADVAIR DISKUS 81 73 34 32
CALCIUM 81 63 34 250
PRAVASTATIN SODIUM 74 65 36 41
LIDODERM 69 69 37 29
LIPITOR 68 65 38 146
ALLOPURINOL 62 62 39 43
CALCIUM 500 + D 59 50 10 40 273
ISOSORBIDE MONONITRATE ER 58 58 41 36
SPIRIVA 57 50 42 46
TRAMADOL HCL 56 47 43 26
OYSTER SHELL CALCIUM 56 56 43 282
LOSARTAN POTASSIUM 55 55 45 34
PREDNISONE 55 40 45 31
METOPROLOL SUCCINATE 54 51 47 16
ROXICODONE 53 45 S2 10 48 291
DILTIAZEM 24HR ER 50 38 49 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.